GSK (ADR)
Develops specialty medicines and vaccines through immune-system science and advanced technologies.
$50.57
After-hours close−0.26 (−0.51%)
At close$50.83(+1.11%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 17.33%Insiders —
Shares outstanding 2.00B · Float 1.94B · 96.9% free float
Institutions13F, as of Jun 30, 2026
1,070 holders · 347.18M shares · 112 new positions · 495 increased · 338 reduced · 104 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 64.96M | 3.24% | −2.70M | Aug 13, 2026 |
| Dodge & Cox | 48.20M | 2.41% | −10.47M | Aug 13, 2026 |
| Fisher Asset Management, LLC | 35.72M | 1.78% | +1.20M | Aug 4, 2026 |
| Primecap Management Co/CA/ | 25.18M | 1.26% | −22.5K | Aug 14, 2026 |
| Wellington Management Group LLP | 11.40M | 0.57% | −321.4K | Aug 14, 2026 |
| JTC Employer Solutions Trustee Ltd | 8.59M | 0.43% | −449.4K | Jul 31, 2026 |
| Morgan Stanley | 7.66M | 0.38% | −3.37M | Aug 13, 2026 |
| Royal Bank of Canada | 7.59M | 0.38% | +82.1K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.90% | 369.58M | 13G | Mar 7, 2025 ↗ |
| FMR LLC | 5.80% | 234.94M | 13G | May 6, 2026 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.